Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

CAF Applauds Efforts of Rep. Markey & Sen. Mikulski to Increase Funding for Alzheimer’s Research

Congressman Ed Markey (D-MA) and Senator Barbara Mikulski (D-MD) have introduced resolutions urging the United States Postal Service to issue a stamp to fund Alzheimer’s disease research at the National Institutes of Health. The “semipostal”  stamp would have its proceeds specifically directed for additional Alzheimer’s disease research through the NIH.

Two CAF Research Consortium Members Featured in January Nature Article

On January 6, an article by Robert C. Malenka and Roberto Malinow was published in the journal Nature. Malenka and Malinow's article, both of whom are Cure Alzheimer's Fund Research Consortium Members, focused on recent research surrounding the causes of Alzheimer's and studies in mice that have pinpointed specific regions and proteins within the brain thought to be associated with the disease.

Read the full article



Dr. Gandy's Research Presented at International Conference in Paris

Dr. Sam Gandy, a CAF Research Consortium member, and Rachel Lane, a postdoctoral researcher in Gandy's lab, presented their findings today at the Alzheimer's Annual International Conference in Paris. Their research identified a gene, called SorCS1, that is for a protein that can cause Type 2 diabetes and also may kill nerve cells in the brain, thus contributing to Alzheimer's.

According to a statement released by Mount Sinai School of Medicine in New York, where Dr. Gandy is the Associate Director of the Alzheimer's Disease Research Center:

NBC Interviews Dr. Sam Gandy, CAF Research Consortium Member

Dr. Sam Gandy's article, entitled "Prevention is Better than Cure," was featured last week in the journal Nature. NBC highlighted Dr. Gandy's perspective and research in an interview on the nightly news and on their website. Gandy, who is a CAF Research Consortium member, will be sending members of his lab to Paris this week to attend the Alzheimer's Association's Annual International Conference.

Read the NBC Article

View the NBC video (coming soon).

CAF Research Consortium Member featured in Nature Weekly Release

On Wednesday, July 13, Dr. Sam Gandy's commentary regarding the early treatment of Alzheimer's was featured in a weekly press release sent out by Nature. Gandy, a CAF research consortium member, submitted a Perspective column addressing the need for early testing.

Here's an excerpt from the press release:

VIDEO: TEDMED 2010 Sparks Discussion on AD Treatment and Funding

Cure Alzheimer's Fund co-founder and venture capitalist Henry McCance and Dr. Rudolph Tanzi discuss the latest research on Alzheimer's, the hope of discovering a cure by 2020 and the success of using a venture capital funding model to spur on research at TEDMED 2010.

Alzheimer's Reading Room, a leading source of Alzheimer's news and information, covered McCance and Tanzi's presentation at TEDMED. The blog entry can be viewed here.

Alan Arnette Reaches 14,000 ft on Mt. McKinley Climb

Alan Arnette has reached the 14,000 ft camp on Mt. McKinley on his "7-Summits Climb for Alzheimer's: Memories Are Everything" expedition. Alan and his team encountered strong winds on their climb but successfully navigated the dangerous “Windy Corner,” a crossing under unstable rock.

The team will move to High Camp at 17,000 ft on Saturday, July 9, with a potential summit attempt on Monday, July 11. Part of the money raised by Alan's 7-Summits campaign goes toward Cure Alzheimer's Fund.

AOL Healthy Living/Huffington Post by Alan Arnette on his 7-Summits Climb for Alzheimer's

Alan Arnette discusses his journey to raise awareness and funds for Alzheimer's on his "7-Summits Climb for Alzheimer's: Memories Are Everything." He reflects on his Everest summit and how he was reminded of the struggles his mother faced while battling Alzheimer's. Funds raised on his campaign will be contributed to Cure Alzheimer's Fund.

Read the full blog


Dr. Malenka elected to National Academy of Sciences

Cure Alzheimer’s Fund Research Consortium Member recognized
for Work on Neuroscience and Neuropsychiatric Disorders

Boston— Praised for excellence in his innovative neuroscience research, Stanford University’s Dr. Robert Malenka, M.D., Ph.D. has been elected to the National Academy of Sciences. A member of Cure Alzheimer’s Fund Research Consortium, Malenka is the Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences, and director of the Nancy Friend Pritzker Laboratory at Stanford University.